Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 524
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04042597 | Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic Chordoma | ||
| NCT04543695 | A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer | ||
| NCT06481449 | Definitive Radiotherapy for Cervical and Upper Thoracic Esophageal Cancer (ChC&UES): A Multi-center Real World Study | ||
| NCT07351266 | Multi-omics Analysis of Renal Cell Carcinoma Mechanisms; Drug Sensitivity Testing in Patient-Derived Cell-based Microtumors | ||
| NCT06087068 | Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma | ||
| NCT07141771 | An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing | ||
| NCT06752148 | Quantitative Neurofeedback Techniques for Treating Perioperative Cognitive Disorders in Elderly Patients | ||
| NCT06833216 | Familial Breast Cancer in China | ||
| NCT06481553 | RWS of Paclitaxel Liposome Combined With Anti-HER-2 Monoclonal Antibody | ||
| NCT02681822 | Multi-center Imaging Genetics Studies in China | ||
| NCT07014202 | Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy | ||
| NCT03511170 | XELOX and XELIRI Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer | ||
| NCT02981641 | IORT Versus CCRT for Pancreatic Cancer | ||
| NCT06405256 | Magnetic Resonance Imaging-guided Adaptive Radiotherapy for Large Brain Metastases | ||
| NCT07480863 | Treatment of BTKi+Hi-CVP Regimen for Previously Untreated MZL | ||
| NCT06543836 | ctDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer | ||
| NCT04755907 | 3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases | ||
| NCT06452433 | Gumarontinib Combined With 3rd EGFR-TKI in Patients With Non-small Cell Lung Cancer. | ||
| NCT02053948 | Pursestring Wound Closure vs "Gunsight" Skin Incision and Closure Technique to Reverse Stoma | ||
| NCT02503150 | Trial of Antigen Pulsed Dendritic Cells (APDC) in Metastatic Colorectal Cancer | ||
| NCT06490068 | Study of LTC004 Combine With Toripalimab in Patient With Solid Tumors Resistant to Immunotherapy | ||
| NCT01492556 | Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer | ||
| NCT02635503 | Safety Study of Totally Laparoscopic Resection With Natural Orifice Specimen Extraction (NOSE) for Rectosigmoid Cancer | ||
| NCT07156019 | Sintilimab in Combination With Surufatinib and Temozolomide in the Advanced Neuroendocrine Carcinoma | ||
| NCT05983094 | Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast Cancer | ||
| NCT06889402 | Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy | ||
| NCT06540937 | Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor | ||
| NCT06839547 | A Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tumor Drug As a Radiosensitizer in Patients with Advanced Breast Cancer Brain Metastasis. | ||
| NCT06312982 | A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer | ||
| NCT05497739 | Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer | ||
| NCT06078930 | Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms | ||
| NCT07099794 | A Randomized, Two-cohort, Prospective Phase II Clinical Study of the Second-line Treatment of Advanced Biliary System Tumors With Liposomal Irinotecan (II) Combination Regimen | ||
| NCT06615466 | Super-Hypofractionated Partial Breast Irradiation | ||
| NCT04947995 | Multi-Omics Noninvasive Inspection of TumOr Risk for Gastric Cancer | ||
| NCT07164872 | Neoadjuvant Chemotherapy Combined With Preoperative Radiotherapy for Locally Advanced Breast Cancer | ||
| NCT07461727 | An Open-Label, Single-Arm, Dose-Escalation Phase I Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of EDB-102 in Patients With EGFR L858R-Mutant, Third-Generation TKI-Resistant Advanced Non-Small Cell Lung Cancer With Liver Metastases | ||
| NCT05951127 | Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCC | ||
| NCT06667622 | Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy | ||
| NCT06342336 | HS-IT101 Injection in the Treatment of Advanced Solid Tumors | ||
| NCT07057102 | Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer | ||
| NCT06038461 | An Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1 in the First-line Treatment of Advanced Neuroendocrine Tumors | ||
| NCT06858956 | Real-World Study of Chidamide Combined With PD-(L)1 Inhibitors and Anti-Angiogenic Therapy for Advanced MSS-Type Colorectal Cancer | ||
| NCT03583580 | Accelerated Partial Breast Irradiation With IMRT in Early Breast Cancer | ||
| NCT06750861 | QL1706 Plus Chemotherapy With AG Regime as First-line Treatment of Advanced PDAC | ||
| NCT06857747 | Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer. | ||
| NCT06178601 | A Study of RC48-ADC Combined With Cadonilimab（AK104）in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma | ||
| NCT06987500 | A Study of PARG Inhibitor XNW29016 in Patients With Advanced Solid Tumors Who Failed Standard Treatment | ||
| NCT05886439 | LK101 Combined With PD-1 or PD-L1 Monoclonal Antibody in the Treatment of Lung Cancer | ||
| NCT04972201 | A Proof of Concept Study of Pan-cancer Early Detection by Liquid Biopsy | ||
| NCT04664439 | Follow-up With CT-FFR in CHD Patients After DCB |
